Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antonella Poloni

Showing results (41-50 of 81) with videos related to

Pageof 9
Sort By:
Clinical Lymphoma, Myeloma & Leukemia|November 8, 2024
Lenalidomide in Transfusion-Dependent IPSS Low- or Intermediate-1-Risk Myelodysplastic Syndromes and Isolated Del(5q): Results of a European Postauthorization Safety Surveillance StudyAntonella Poloni, Klas Raaschou-Jensen, Francisca Hernandez Mohedo, et al.
Transfusion|January 10, 2003
Long-term hematologic reconstitution after autologous peripheral blood progenitor cell transplantation: a comparison between controlled-rate freezing and uncontrolled-rate freezing at 80 degrees CMauro Montanari, Debora Capelli, Antonella Poloni, et al.
Biomedicines|April 23, 2022
Novel Translational Read-through-Inducing Drugs as a Therapeutic Option for Shwachman-Diamond SyndromeValentino Bezzerri, Laura Lentini, Martina Api, et al.
The Oncologist|April 26, 2012
Tailored therapy in an unselected population of 91 elderly patients with DLBCL prospectively evaluated using a simplified CGAAttilio Olivieri, Guido Gini, Caterina Bocci, et al.
American Journal of Hematology|April 26, 2024
Unveiling the genetic landscape of suspected congenital dyserythropoietic anemia type I: A retrospective cohort study of 36 patientsRoberta Marra, Antonella Nostroso, Barbara Eleni Rosato, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 1, 2014
Mobilization-driven postconsolidation therapy in elderly patients with acute myeloid leukemia: feasibility and efficacy of autologous stem cell transplantation versus low-dose gemtuzumab ozogamicinDebora Capelli, Martina Chiarucci, Antonella Poloni, et al.
European Journal of Haematology|May 18, 2013
Prognostic role of immunohistochemical analysis of 5 mc in myelodysplastic syndromesAntonella Poloni, Gaia Goteri, Antonio Zizzi, et al.
American Journal of Blood Research|September 20, 2021
Accuracy of bone marrow histochemical TP53 expression compared to the detection of TP53 somatic mutations in patients with myelodysplastic syndromes harbouring a del5q cytogenetic abnormalityEsther N Oliva, Roberto Latagliata, Elena Sabattini, et al.
The Journal of Clinical Investigation|March 31, 2015
Specific molecular signatures predict decitabine response in chronic myelomonocytic leukemiaKristen Meldi, Tingting Qin, Francesca Buchi, et al.
Hemasphere|February 2, 2026
Prognostic value of flow cytometry in myelodysplastic neoplasms (MDS): Composition of a FCM-prognostic score (FCM-PS) for overall survivalAida Santaolalla, Uta Oelschlaegel, Susann Winter, et al.
Pageof 9

Showing results (41-50 of 81) with videos related to

Sort By:
Pageof 9
Clinical Lymphoma, Myeloma & Leukemia|November 8, 2024
Lenalidomide in Transfusion-Dependent IPSS Low- or Intermediate-1-Risk Myelodysplastic Syndromes and Isolated Del(5q): Results of a European Postauthorization Safety Surveillance StudyAntonella Poloni, Klas Raaschou-Jensen, Francisca Hernandez Mohedo, et al.
Transfusion|January 10, 2003
Long-term hematologic reconstitution after autologous peripheral blood progenitor cell transplantation: a comparison between controlled-rate freezing and uncontrolled-rate freezing at 80 degrees CMauro Montanari, Debora Capelli, Antonella Poloni, et al.
Biomedicines|April 23, 2022
Novel Translational Read-through-Inducing Drugs as a Therapeutic Option for Shwachman-Diamond SyndromeValentino Bezzerri, Laura Lentini, Martina Api, et al.
The Oncologist|April 26, 2012
Tailored therapy in an unselected population of 91 elderly patients with DLBCL prospectively evaluated using a simplified CGAAttilio Olivieri, Guido Gini, Caterina Bocci, et al.
American Journal of Hematology|April 26, 2024
Unveiling the genetic landscape of suspected congenital dyserythropoietic anemia type I: A retrospective cohort study of 36 patientsRoberta Marra, Antonella Nostroso, Barbara Eleni Rosato, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 1, 2014
Mobilization-driven postconsolidation therapy in elderly patients with acute myeloid leukemia: feasibility and efficacy of autologous stem cell transplantation versus low-dose gemtuzumab ozogamicinDebora Capelli, Martina Chiarucci, Antonella Poloni, et al.
European Journal of Haematology|May 18, 2013
Prognostic role of immunohistochemical analysis of 5 mc in myelodysplastic syndromesAntonella Poloni, Gaia Goteri, Antonio Zizzi, et al.
American Journal of Blood Research|September 20, 2021
Accuracy of bone marrow histochemical TP53 expression compared to the detection of TP53 somatic mutations in patients with myelodysplastic syndromes harbouring a del5q cytogenetic abnormalityEsther N Oliva, Roberto Latagliata, Elena Sabattini, et al.
The Journal of Clinical Investigation|March 31, 2015
Specific molecular signatures predict decitabine response in chronic myelomonocytic leukemiaKristen Meldi, Tingting Qin, Francesca Buchi, et al.
Hemasphere|February 2, 2026
Prognostic value of flow cytometry in myelodysplastic neoplasms (MDS): Composition of a FCM-prognostic score (FCM-PS) for overall survivalAida Santaolalla, Uta Oelschlaegel, Susann Winter, et al.
Pageof 9